Is Aldeyra The (ALDX) overvalued? · $112.2M cap
Aldeyra The (ALDX) is a biotechnology company listed on US.
This page asks whether Aldeyra The (ALDX) looks expensive on cached numbers — not a short thesis.
No cached income statement for ALDX, so there is no earnings base to call rich or cheap.
ALDX currently screens at market cap $112.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ALDX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ALDX stock page for the full model, not this heading.
Not investment advice.